Counterregulation to hypoglycaemia: Physiology

Annales d'Endocrinologie

Volumn 65, Issue 1, 2004, Pages 85-87

  Amiel, S A ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON; GLUCOSE; INSULIN; POTASSIUM CHANNEL; SULFONYLUREA DERIVATIVE;

CONFERENCE PAPER; DIABETES MELLITUS; DIET RESTRICTION; EXERCISE; GLUCAGON RELEASE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN RELEASE; NONHUMAN; PANCREAS ISLET BETA CELL;

EID: 2342566529     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0003-4266(04)95638-7     Document Type: Conference Paper

References (35)

1. Amiel SA, Archibald HR, Chusney G, Williams AJK, Gale EAM. Ketone infusion lowers hormonal responses to hypoglycaemia: evidence for acute cerebral utilization of a non-glucose fuel. Clin Sci 1991; 81: 189-4.
2. Amiel SA, Sherwin RS, Simonson DC, Tamborlane WV. Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release. Diabetes 1988; 37: 901-7.
3. Amiel SA, Simonson DC, Sherwin RS, Lauritano AA, Tamborlane WV. Exaggerated epinephrine responses to hypoglycemia in normal and insulin-dependent diabetic children. Journal of Pediatrics 1987; 110: 832-7.
4. Bolli G, DeFeo P, Campugnucci P et al. Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin antibodies and impaired glucagon secretion. Diabetes 1983: 32; 134-1.
5. Borg WP, Sherwin RS, During MJ, Borg MA, Shulman GI. Local ventromedial hypothalamus glucopenia triggers counterregulatory hormone release. Diabetes 1995; 44: 180-4.
6. Borg MA, Tamborlane WV, Shulman GI, Sherwin RS. Local lactate perfusion of the ventromedial hypothalamus suppresses hypoglycemic counterregulation. Diabetes 2003; 52: 663-6.
7. Cranston IC, Reed LJ, Marsden PK, Amiel SA. Changes in regional brain 18F-fluorodeoxyglucose uptake at hypoglycemia in Type 1 diabetic men associated with hypoglycemia unawareness and counterregulatory failure. Diabetes 2001; 50: 2329-36.
8. Donovan CM, Hamilton-Wessler M, Halter JB, Bergman RN. Primacy of liver glucosensors in the sympathetic response to progressive hypoglycemia. Proc Natl Acad Sci U S A 1994; 91: 2863-7.
9. Dunn-Meynell AA, Routh VH, Kang L, Gaspers L, Levin BE. Glucokinase is the likely mediator of glucosensing in both glucose-excited and glucose-inhibited central neurons. Diabetes 2002; 51: 2056-65.
10. During MJ, Leone P, Davis KE, Kerr D, Sherwin RS. Glucose modulates rat substantia nigra GABA release in vivo via ATP-sensitive potassium channels. J Clin Invest 1995; 95: 2403-8.
11. Evans ML, Pernet A, Lomas J, Jones J, Amiel SA. Delay in onset of awareness of acute hypoglycaemia and of restoration of cognitive performance during recovery. Diabetes Care 2000; 23: 893-7.
12. Fery F, Plat L, van de Borne P, Cogan E, Mockel J. Counter-regulation of glucose in a patient with hypothalamic sarcoidosis. N Engl J Med. 1999; 340: 852-6.
13. Garcia MA, Millan C, Balmaceda-Aguilera C et al. Hypothalamic ependymal-glial cells express the glucose transporter GLUT2, a protein involved in glucose sensing. J Neurochem 2003; 86: 709-24.
14. Guenat E, Seematter G, Ohillipe J, Temler E, Jequier E, Tappy L. Counterregulatory responses to hypoglycemia in patients with glucokinase gene mutations. Diabetes Metab 2000; 26: 377-384.
15. Hamilton-Wessler M, Bergman RN, Halter JB, Watanabe RM, Donovan CM. The role of liver glucosensors in the integrated sympathetic response induced by deep hypoglycemia in dogs. Diabetes 1994; 43: 1052-60.
16. Heller SR, Cryer PE. Reduced neuroendocrine and symptomatic responses to subsequent hypoglycaemia in non-diabetic humans. Diabetes 1991; 40: 223-6.
17. Hevener AL, Bergman RN, Donovan CM. Novel glucosensor for hypoglycemic detection localized to the portal vein. Diabetes 1997; 46: 1521-5.
18. Horowitz M, O'Donovan D, Jones KL, Feinle C, Rayne CK, Samsom M. Gastric emptying in diabetes: clinical significance and treatment. Diabet Med. 2002; 19: 177-94.
19. Landstedt-Hallin L, Adamson U, Lins PE. Oral glibenclamide suppresses glucagon secretion during insulin-induced hypoglycemia in patients with type 2 diabetes. J Clin Endocrinol Metab 1999; 84: 3140-5.
20. Lee K, Dixon AK, Richardson PJ, Pinnock RD. Glucose receptive neurones in the rat ventromedial hypothalamus express KATP channels composed of Kir 6.1 and SUR1 subunits. Journal of Physiology 1999; 515.2: 439-52.
21. Liu Y, Gao JH, Liu H-L, Fox PT. The temporal response of the brain after eating revealed by functional magnetic resonance imaging. Nature 2000; 405: 1058-1062.
22. Lynch RM, Tompkins LS, Brooks HL, Dunn-Meynell AA, Levin BE. Localization of glucokinase gene expression in the rat brain Diabetes. 2000; 49: 693-700.
23. Maran A, Cranston I, Lomas J, Macdonald IA, Amiel SA. Protection by lactate of cerebral function during hypoglycaemia. Lancet 1994; 343: 16-20.
24. Maran A, Lomas J, Macdonald IA, Amiel SA. Lack of preservation of higher brain function during hypoglycaemia in patients with intensively treated IDDM. Diabetologia 1995; 38: 1412-8.
25. Matyka K, Evans M, Lomas J, Korzon-Burakowska A, Cranston I, Macdonald I, Amiel SA. Altered hierarchy of protective responses against severe hypoglycemia in normal aging in healthy men. Diabetes Care 1997; 20: 135-41.
26. Mitrakou A, Ryan C, Veneman T et al. Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms and cerebral dysfunction. Am J Physiol 1991; 260: E67-E74.
27. Peacey SR, Rostami-Hodjegan A, George E, Tucker GT, Heller SR. The use of tolbutamide-induced hypoglycemia to examine the intraislet role of insulin in mediating glucagon release in normal humans. Clin Endocrinol Metab 1997; 82: 1458-61.
28. Ritter S, Dinh TT, Llwellyn Smith I. Subgroups of hindbrain catecholamine neurons are selectively activated by 2-deoxy-D-glucose induced metabolic challenge. Brain Res 1998; 805: 41-45.
29. Rizza RA, Cryer PE, Gerich JE. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation: effects of somatostatin and combined alpha- and beta-blockade on plasma glucose recovery and glucose flux rates following insulin induced hypoglycaemia. J Clin Invest 1979; 64: 62-71.
30. Saunders NM, Ritter S. Repeated 2DG induced glucoprivation attenuates fos expression and glucoregulatory responses during subsequent glucoprivation. Diabetes 2000; 49: 1865-1874.
31. Smith D, Pernet A, Reid H et al. The role of hepatic portal glucose sensing in modulating responses to hypoglycemia. Diabetologia 2002; 45: 1416-24.
32. Song Z, Levin BE, McArdle JJ, Bakhos N, Routh VH. Convergence of pre- and postsynaptic influences on glucosensing neurons in the ventromedial hypothalamic nucleus. Diabetes 2001; 50: 2673-81.
33. Spyer G, Hattersely AT, Macdonald IA, Amiel SA, MacLeod KM. Hypoglycaemic conunterregulation at "normal" blood glucose concentrations in patients with well-controlled Type 2 diabetes. Lancet 2000; 356; 1970-4.
34. Tataranni PA, Gautier JF, Chen K et al. Neuroanatomical correlates of hunger and satiation in humans using positron emission tomography. Proc Natl Acad Sci U S A 1999; 96: 4569-74.
35. Veneman T, Mitrakou A, Mokan M, Cryer P, Gerich J. Effect of hyperketonemia and hyperlacticacidemia on symptoms, cognitive dysfunction and counterregulatory hormone responses during hypoglcyemia in normal humans. Diabetes 1994; 43: 1311-7.